Related Experiment Video
Updated: Jun 2, 2026

Three-Dimensional Cephalometric Landmark Annotation Demonstration on Human Cone Beam Computed Tomography Scans
Published on: September 8, 2023
BHMT gene polymorphisms as risk factors for cleft lip and cleft palate in a Chinese population
1Beijing Stomatological Hospital, Capital Medical University, Beijing 100050, China. huying_369@yahoo.com.cn
Insights
Genetic variations in the betaine-homocysteine methyltransferase (BHMT) gene may increase the risk of nonsyndromic cleft lip with or without cleft palate (NSCL/P). Specifically, the BHMT rs3797546 polymorphism is associated with NSCL/P in a recessive manner.
Area of Science:
- Genetics
- Developmental Biology
- Public Health
Background:
- Maternal folic acid intake is linked to nonsyndromic cleft lip with or without cleft palate (NSCL/P) risk.
- Genetic factors may also play a role in NSCL/P etiology.
Purpose of the Study:
- To investigate the association between genetic variations in the betaine-homocysteine methyltransferase (BHMT) gene and NSCL/P.
- To explore the role of specific BHMT single nucleotide polymorphisms (SNPs) in NSCL/P susceptibility.
Main Methods:
- Genotyping of three BHMT SNPs (rs651852, rs3797546, rs3733890) using real-time PCR.
- Case-control study involving 166 NSCL/P patients and 285 healthy controls.
Main Results:
- No significant association was found for BHMT SNPs rs651852 and rs3733890 with NSCL/P.
- The CC genotype of BHMT SNP rs3797546 showed a higher prevalence in NSCL/P patients compared to TT+CT genotypes (P=0.020, OR=2.10).
Conclusions:
- The BHMT gene polymorphism rs3797546 may confer a genetic risk for NSCL/P.
- This association appears to be recessive, suggesting a potential genetic predisposition to NSCL/P.
Objective:
Convincing evidence suggests a link between increased risk of nonsyndromic cleft lip with or without cleft palate (NSCL/P) and low intake of folic acid by the mother during pregnancy. The present study was designed to explore if genetic variation in the betaine-homocysteine methyltransferase (BHMT) gene contributes to NSCL/P.
Methods:
DNA was obtained from 166 individuals with NSCL/P and 285 healthy subjects. Three known single nucleotide polymorphisms (SNPs) present in the BHMT gene (rs651852, rs3797546, and rs3733890) were investigated by real-time PCR-based TaqMan genotyping.
Results:
Neither allelic nor genotypic association was found between NSCL/P and SNPs rs651852 and rs3733890. SNP rs3797546 did not show allelic association with NSCL/P; however, a higher proportion of NSCL/P patients carry the CC genotype compared with the TT+CT genotype (P=0.020, OR=2.10, 95% CI=1.11-3.95).
Conclusion:
Our study suggests that polymorphism rs3797546 in the BHMT gene may confer genetic risk of NSCL/P in a recessive manner.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic Lingo
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Probability Laws
Principles of Pharmacogenetics: Types of Genetic Variants
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
